Variant report
Variant | nsv892245 |
---|---|
Chromosome Location | chr9:8916449-8937478 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:35)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:35 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr9:8926157-8926470 | IMR90 | lung: | n/a | chr9:8926304-8926313 chr9:8926302-8926313 chr9:8926304-8926315 |
2 | CEBPB | chr9:8926156-8926446 | HepG2 | liver: | n/a | chr9:8926304-8926313 chr9:8926302-8926313 chr9:8926304-8926315 |
3 | CTCF | chr9:8918480-8918630 | HepG2 | liver: | n/a | n/a |
4 | CTCF | chr9:8918420-8918570 | HEK293 | kidney: | n/a | n/a |
5 | CTCF | chr9:8919660-8919810 | AG04449 | skin: | n/a | n/a |
6 | CTCF | chr9:8918420-8918570 | RPTEC | kidney: | n/a | n/a |
7 | CTCF | chr9:8918478-8918573 | HepG2 | liver: | n/a | n/a |
8 | FOS | chr9:8924604-8925118 | MCF10A-Er-Src | breast: | n/a | chr9:8924767-8924778 chr9:8924768-8924776 chr9:8924766-8924778 chr9:8924766-8924773 |
9 | FOS | chr9:8924605-8924901 | MCF10A-Er-Src | breast: | n/a | chr9:8924767-8924778 chr9:8924768-8924776 chr9:8924766-8924778 chr9:8924766-8924773 |
10 | FOS | chr9:8923674-8924056 | MCF10A-Er-Src | breast: | n/a | chr9:8923846-8923853 chr9:8923844-8923853 |
11 | FOS | chr9:8923693-8923902 | MCF10A-Er-Src | breast: | n/a | chr9:8923846-8923853 chr9:8923844-8923853 |
12 | FOS | chr9:8924604-8924901 | MCF10A-Er-Src | breast: | n/a | chr9:8924767-8924778 chr9:8924768-8924776 chr9:8924766-8924778 chr9:8924766-8924773 |
13 | FOS | chr9:8923660-8924001 | MCF10A-Er-Src | breast: | n/a | chr9:8923846-8923853 chr9:8923844-8923853 |
14 | FOS | chr9:8923688-8923899 | MCF10A-Er-Src | breast: | n/a | chr9:8923846-8923853 chr9:8923844-8923853 |
15 | FOSL2 | chr9:8923670-8923912 | HepG2 | liver: | n/a | chr9:8923846-8923853 chr9:8923844-8923853 |
16 | FOXA1 | chr9:8932386-8932868 | HepG2 | liver: | n/a | n/a |
17 | FOXA2 | chr9:8932424-8932905 | A549 | lung: | n/a | n/a |
18 | JUN | chr9:8925967-8926200 | HepG2 | liver: | n/a | n/a |
19 | JUN | chr9:8919542-8919756 | K562 | blood: | n/a | n/a |
20 | JUND | chr9:8925913-8926211 | HepG2 | liver: | n/a | n/a |
21 | MAX | chr9:8923742-8923931 | NB4 | blood: | n/a | chr9:8923779-8923789 |
22 | MYC | chr9:8923625-8923961 | MCF10A-Er-Src | breast: | n/a | chr9:8923779-8923789 chr9:8923741-8923751 |
23 | MYC | chr9:8919669-8919869 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | MYC | chr9:8923652-8923852 | MCF10A-Er-Src | breast: | n/a | chr9:8923779-8923789 chr9:8923741-8923751 |
25 | PAX5 | chr9:8919636-8919867 | GM12878 | blood: | n/a | n/a |
26 | PAX5 | chr9:8919585-8919870 | GM12878 | blood: | n/a | n/a |
27 | PAX5 | chr9:8919639-8919782 | GM12878 | blood: | n/a | n/a |
28 | POLR2A | chr9:8933128-8933140 | MCF-7 | breast: | n/a | n/a |
29 | POLR2A | chr9:8933043-8933121 | MCF-7 | breast: | n/a | n/a |
30 | POLR2A | chr9:8919691-8919724 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr9:8926488-8926679 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | STAT3 | chr9:8924573-8924802 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | STAT3 | chr9:8923782-8923895 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | SUZ12 | chr9:8919685-8920019 | H1-hESC | embryonic stem cell: | n/a | n/a |
35 | USF2 | chr9:8917837-8917925 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-KDM4C-9 | chr9:8936079-8936179 | ENSG00000234021 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234021 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10046838 | chr9:8916449-8916450 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs115474938 | chr9:8916529-8916530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184701123 | chr9:8916545-8916546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550969192 | chr9:8916596-8916597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569294605 | chr9:8916603-8916604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79416228 | chr9:8916607-8916608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548711446 | chr9:8916642-8916643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561404025 | chr9:8916646-8916647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566927770 | chr9:8916682-8916683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534287698 | chr9:8916692-8916693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189063412 | chr9:8916744-8916745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181447550 | chr9:8916756-8916757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538169888 | chr9:8916804-8916805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556157861 | chr9:8916808-8916809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574102566 | chr9:8916852-8916853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541377665 | chr9:8916871-8916872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559714193 | chr9:8916882-8916883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185741620 | chr9:8916888-8916889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147103040 | chr9:8916904-8916905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528591337 | chr9:8916906-8916907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565500524 | chr9:8916925-8916926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191308722 | chr9:8916927-8916928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556115215 | chr9:8916960-8916961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576171735 | chr9:8916975-8916976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs202033253 | chr9:8917054-8917055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573630592 | chr9:8917055-8917056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541801261 | chr9:8917058-8917059 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs61077928 | chr9:8917070-8917071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530122496 | chr9:8917072-8917073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561646035 | chr9:8917103-8917104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542752335 | chr9:8917115-8917116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559048705 | chr9:8917133-8917134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs201814682 | chr9:8917135-8917136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371386589 | chr9:8917136-8917137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201360519 | chr9:8917137-8917138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34621501 | chr9:8917149-8917150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10977359 | chr9:8917151-8917152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574496600 | chr9:8917171-8917172 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs137923605 | chr9:8917174-8917175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143390188 | chr9:8917182-8917183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552369545 | chr9:8917197-8917198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570648882 | chr9:8917202-8917203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565568185 | chr9:8917253-8917254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537601797 | chr9:8917260-8917261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560229058 | chr9:8917276-8917277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574439457 | chr9:8917278-8917279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs180976235 | chr9:8917282-8917283 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs35338026 | chr9:8917284-8917285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553382989 | chr9:8917290-8917291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79698622 | chr9:8917293-8917294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:8913800-8916800 | Enhancers | Brain Angular Gyrus | brain |
2 | chr9:8913800-8916800 | Enhancers | Brain Substantia Nigra | brain |
3 | chr9:8913800-8918400 | Enhancers | Brain Inferior Temporal Lobe | brain |
4 | chr9:8914800-8916800 | Enhancers | Brain Hippocampus Middle | brain |
5 | chr9:8915600-8918200 | Enhancers | Brain Cingulate Gyrus | brain |
6 | chr9:8916400-8916800 | Enhancers | Brain Anterior Caudate | brain |
7 | chr9:8916800-8917200 | Weak transcription | Brain Hippocampus Middle | brain |
8 | chr9:8916800-8917800 | Weak transcription | Brain Anterior Caudate | brain |
9 | chr9:8916800-8917800 | Weak transcription | Brain Substantia Nigra | brain |
10 | chr9:8916800-8918200 | Weak transcription | Brain Angular Gyrus | brain |
11 | chr9:8917000-8918800 | Enhancers | Dnd41 | blood |
12 | chr9:8917200-8918400 | Enhancers | Brain Hippocampus Middle | brain |
13 | chr9:8917200-8918400 | Enhancers | Fetal Thymus | thymus |
14 | chr9:8917600-8918200 | Enhancers | Primary T cells from cord blood | blood |
15 | chr9:8917800-8918200 | Enhancers | Brain Anterior Caudate | brain |
16 | chr9:8917800-8918200 | Enhancers | Brain Substantia Nigra | brain |
17 | chr9:8918000-8918200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
18 | chr9:8918200-8918400 | Enhancers | Brain Angular Gyrus | brain |
19 | chr9:8923400-8924800 | Enhancers | Osteobl | bone |
20 | chr9:8923600-8924800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
21 | chr9:8923600-8925200 | Enhancers | Muscle Satellite Cultured Cells | -- |
22 | chr9:8923800-8925200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
23 | chr9:8933400-8934200 | Enhancers | Fetal Heart | heart |
24 | chr9:8937000-8939000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |